Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of Efalizumab in cutaneous T-cell lymphoma
2007-006126-10Phase 2Terminated
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jul 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of efalizumab in cutaneous T-cell lymphoma (CTCL) and Sézary syndrome (SS), sponsored by Charité – Universitätsmedizin Berlin. Started Jul 2008; status: terminated.
02
Drugs
efalizumab
03
Conditions
cutaneous T-cell lymphoma (CTCL)Sézary syndrome (SS)
Beyond the preview
Go deeper on 2007-006126-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006126-10.